Scancell Holdings Plc
("Scancell" or the "Company")
BLOCK LISTING SIX MONTHLY RETURN
Date: 16 February 2021
Name of applicant: |
Scancell Holdings plc |
|||
Name of scheme: |
Convertible Loan Notes Shares
|
|||
Period of return: |
From: |
12 August 2020 |
To: |
15 February 2021 |
Number of securities originally admitted at date of admission |
96,774,193 ordinary shares of £0.001 each 12 August 2020
|
|||
Balance of unallotted securities under scheme(s) from previous return: |
96,774,193 ordinary shares of £0.001 each
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
Less: Number of securities issued/allotted under scheme(s) during period: |
69,719,566 ordinary shares of £0.001 each |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
27,054,627 ordinary shares of £0.001 each
|
|||
|
|
|
|
|
Name of contact: |
Dr Cliff Holloway, CEO |
Telephone number of contact: |
+44 (0) 20 3727 1000 |
For Further Information:
Scancell Holdings plc |
|
|
Dr John Chiplin, Chairman |
|
+44 (0) 20 3727 1000 |
Dr Cliff Holloway, CEO |
|
|
|
|
|
Panmure Gordon (UK) Limited |
|
|
Freddy Crossley/Emma Earl (Corporate Finance) |
|
+44 (0) 20 7886 2500 |
Rupert Dearden (Corporate Broking) |
|
|
|
|
|
FTI Consulting |
|
|
Simon Conway/Natalie Garland-Collins |
|
+44 (0) 20 3727 1000 |